(Rac)-Managlinat dialanetil
Product Specifications
UNSPSC Description
(Rac)-Managlinat dialanetil ((Rac)-MB06322) is a compound for the inhibition of type 2 diabetes that is in Phase II clinical trials and works by inhibiting gluconeogenesis.
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/rac-managlinat-dialanetil.html
Smiles
O=C(C(C)NP(NC(C)C(OCC)=O)(C1=CC=C(C2=C(CC(C)C)SC(N)=N2)O1)=O)OCC
Molecular Weight
500.55
References & Citations
[1]Managlinat dialanetil, a fructose-1,6-bisphosphatase inhibitor for the treatment of type 2 diabetes
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14955A/Rac-Managlinat-dialanetil-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14955A/
Clinical Information
No Development Reported
CAS Number
347870-26-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC205844L1V 200 µL
BubR1 (BUB1B) (NM_001211) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 